Search Results 2001-2010 of 18397 for Core activity limitation

  1. Medical Research & Education - Mayo Clinic News Network

    Research. Antifibrotics may extend lives for patients with IPF. Joel Streed. September 21, 2021. Mayo Clinic leads biorepository core for new nationwide ...

  2. Medical Research & Education - Mayo Clinic News Network

    Research. Antifibrotics may extend lives for patients with IPF. Joel Streed. September 21, 2021. Mayo Clinic leads biorepository core for new nationwide ...

  3. Medical Research & Education - Mayo Clinic News Network

    Research. Antifibrotics may extend lives for patients with IPF. Joel Streed. September 21, 2021. Mayo Clinic leads biorepository core for new nationwide ...

  4. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers use AI to predict patient falls based on core density in middle age. ROCHESTER, Minn. — Artificial intelligence (AI) applied to ...

  5. Medical Research & Education - Mayo Clinic News Network

    Research. Antifibrotics may extend lives for patients with IPF. Joel Streed. September 21, 2021. Mayo Clinic leads biorepository core for new nationwide ...

  6. Gut Permeability, Sensitivity and Symptomatology - Mayo Clinic

    Core Facilities · Centers ... Alcohol intake beyond the recommended safe limit (<21 units per week). ... Core Facilities · Centers & Programs · Departments ...

  7. Evaluating Childhood Cardiovascular Health Outcomes in NEPTUNE and CureGN - Mayo Clinic

    More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs · Departments & Divisions · Clinical Trials ...

  8. A Study of Vulvovaginal Symptoms in Premenopausal Stage 0-III Breast Cancer Patients Treated on Aromatase Inhibitors and Ovarian Suppression - Mayo Clinic

    Core Facilities · Centers & Programs · Departments ... limit compliance with study requirements. ... Core Facilities · Centers & Programs · Departments ...

  9. Autologous DC Vaccine For RRP Patients - Mayo Clinic

    Total bilirubin ≤ 2 x upper limit ... limit compliance with study requirements. ... More information. Publications. Publications are currently not available. More ...

  10. BT – L-CsA – 301 – SLT: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial To Demonstrate The Efficacy And Safety Of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered Via The PARI Investigational EFlow® Device Plus Standard Of Care Versus Standard Of Care Alone In The Treatment Of Chronic Lung Allograft Syndrome / Bronchiolitis Obliterans Syndrome In Patients Post Single Lung Transplantation - Mayo Clinic

    BT – L-CsA – 301 – SLT: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial To Demonstrate The Efficacy And Safety Of Liposomal ...